1294 related articles for article (PubMed ID: 25243967)
1. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
2. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
[TBL] [Abstract][Full Text] [Related]
3. Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.
Lin X; Zhang Z; Chen JM; Xu YY; Ye HR; Cui J; Fang Y; Jin Y; Zhu DR; Yuan L
Genet Mol Res; 2015 Apr; 14(2):2940-6. PubMed ID: 25966055
[TBL] [Abstract][Full Text] [Related]
4. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
5. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
6. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
7. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
Morio R; Hyogo H; Hatooka M; Morio K; Kan H; Kobayashi T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Masayasu Y; Chayama K
J Gastroenterol; 2017 Feb; 52(2):253-262. PubMed ID: 27351871
[TBL] [Abstract][Full Text] [Related]
8. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
10. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.
Li YL; Xie H; Musha H; Xing Y; Mei CX; Wang HJ; Wulasihan M
Cell Biochem Biophys; 2015 Jul; 72(3):643-7. PubMed ID: 27352181
[TBL] [Abstract][Full Text] [Related]
11. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
[TBL] [Abstract][Full Text] [Related]
12. [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.].
Li FP; Zhang SQ; Wang F; Huang YQ; Fu ZZ; Yan L
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):940-3. PubMed ID: 20079327
[TBL] [Abstract][Full Text] [Related]
13. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
14. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
15. Predictors of non-alcoholic fatty liver disease in obese children.
Sartorio A; Del Col A; Agosti F; Mazzilli G; Bellentani S; Tiribelli C; Bedogni G
Eur J Clin Nutr; 2007 Jul; 61(7):877-83. PubMed ID: 17151586
[TBL] [Abstract][Full Text] [Related]
16. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Lu H; Zeng L; Liang B; Shu X; Xie D
Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
[TBL] [Abstract][Full Text] [Related]
19. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
20. Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
Junker AE; Gluud L; Holst JJ; Knop FK; Vilsbøll T
J Intern Med; 2016 May; 279(5):485-93. PubMed ID: 26728692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]